S. 3741 · In committee · Science, Technology, Communications
Biosecurity Modernization and Innovation Act of 2026
Sponsor: Tom Cotton (R-AR)
What it does
- Requires the Secretary of Commerce to establish regulations within one year mandating that covered providers of synthetic nucleic acids implement screening protocols for sequences of concern and customer identity verification.
- Directs the Secretary to maintain a list of sequences of concern, with expedited procedures for provisional additions and regular public review through a docket, incorporating automated methods such as algorithmic literature scanning.
- Establishes a conformity assessment system including auditing, adversarial testing, and procedures to revoke compliance status for covered providers that fail to meet screening and verification requirements.
- Requires persons receiving Federal funds to purchase nucleic acid synthesis products only from covered providers in compliance with screening and customer verification requirements.
- Directs the Under Secretary of Commerce for Standards and Technology to develop technical standards and best practices for customer screening, order evaluation, and sequence-to-function models within one year.
Latest action
Nov 18, 2026: Committee on Commerce, Science, and Transportation. Ordered to be reported with an amendment in the nature of a substitute favorably.
Committee: Senate Commerce, Science, and Transportation